BCBA/VRTXD (BCBA/VRTXD)

Buenos Aires Stock Exchange: BCBA/VRTXD · USD

$5.48

-0.29 (-5.0%)· Recorded snapshot

Market cap	202.8T
Revenue (ttm)	18.6T
Net income (ttm)	6.5T
EPS (ttm)	$262
P/E (trailing)	32.2x
P/E (forward)	28.8x
Volume	121

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 18.6T
Net income (ttm): 6.5T
EPS (ttm): $262
P/E (trailing): 32.2x
P/E (forward): 28.8x
Market cap: 202.8T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E28.8

P25 n/aP50 n/aP75 n/a

Trailing P/E32.2

P25 n/aP50 n/aP75 n/a

ROE23.5

P25 n/aP50 n/aP75 n/a

ROIC28.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BCBA/VRTXD indicators

Market & fundamental data

Available fields

221

Groups with data

Currency

USD

Showing 221 of 221 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-11-02
Employees	6,400
Employees change	300
Employees growth	4.92%
Enterprise value	$184.9T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-07-12
Fiscal year end	December
Founded	1989
Industry	Biotechnology
Is primary listing	No
ISIN number	AR0468655268
Last earnings date	2026-08-03
Last refreshed	2026-10-28
Market cap	$202.8T
Next earnings date	2026-11-02
Price	$5.48
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-26
Symbol	bcba/VRTXD
Website	https://www.vrtx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	50.03x
Average P/E ratio (3Y)	28.04x
Average P/E ratio (5Y)	26.01x
Earnings yield	3.1%
EV/Earnings	28.38x
EV/EBIT	24.52x
EV/EBITDA	22.32x
EV/FCF	32.93x
EV/Sales	9.57x
FCF / EV yield	3.04%
FCF yield	2.77%
Forward P/E	28.82x
Graham number	1.79044
Graham upside	-67.33%
Lynch fair value	$3.03
Lynch upside	-44.73%
P/(FCF - SBC) ratio	44.13x
P/(OCF - SBC) ratio	38.05x
P/B ratio	6.77x
P/E ratio	32.21x
P/FCF ratio	36.12x
P/OCF ratio	31.94x
P/S ratio	10.89x
Price / tangible book value	7.31x
Price/EBITDA ratio	26.88x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	39%
EBITDA margin	40.52%
Effective tax rate	16.48%
FCF margin	29.05%
Gross margin	54.96%
Operating margin	39%
Pretax margin	41.9%
Profit margin	35%
Profit per employee	$1B
Profitable quarters	8
Profitable years	1
Revenue per employee	$2.9B
ROA	11.93%
ROA (5Y)	14.82%
ROCE	20.9%
ROE	23.54%
ROE (5Y)	19%
ROIC	28.8%
ROIC (5Y)	37.75%
SBC / revenue	5.47%
Tax / revenue	6.91%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	22.12%
EPS growth (Q)	8.02%
EPS growth (QoQ)	7.21%
EPS growth 3Y	9.92%
EPS growth 5Y	17.77%
EPS growth quarters	5
EPS growth years	1
FCF growth	8.47%
FCF growth (Q)	9.25%
FCF growth (QoQ)	-21.74%
FCF growth 3Y	-0.71%
FCF growth 5Y	16.39%
Gross profit growth	15.3%
Gross profit growth (Q)	17.23%
Gross profit growth 3Y	8.01%
Gross profit growth 5Y	11.52%
Net income growth	21.1%
Net income growth (Q)	6.48%
Net income growth (QoQ)	6.63%
Net income growth 3Y	9.4%
Net income growth 5Y	17.2%
Net income growth quarters	5
Net income growth years	1
OCF growth	11.61%
OCF growth (Q)	4.87%
OCF growth (QoQ)	-21.2%
OCF growth 3Y	1.81%
OCF growth 5Y	15.15%
Operating income growth	10.85%
Operating income growth (Q)	9.92%
Operating income growth 3Y	3.16%
Operating income growth 5Y	8.75%
Revenue growth	10.23%
Revenue growth (Q)	12.45%
Revenue growth (QoQ)	11.62%
Revenue growth 10Y	23.24%
Revenue growth 3Y	9.81%
Revenue growth 5Y	13.5%
Revenue growth quarters	33
Revenue growth years	11

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-736B
Depreciation and amortization	$293.7B
EBIT	$7.3T
EBITDA	$7.6T
EPS	$261.69
Financing cash flow	$-3.3T
Free cash flow	$5.6T
Free cash flow minus SBC	$4.6T
Gross profit	$10.2T
Income taxes	$1.3T
Investing cash flow	$-1.3T
Net borrowing	$-8.3B
Net cash flow	$1.7T
Net income	$6.5T
Operating cash flow minus SBC	$5.3T
Operating income	$7.3T
Revenue	$18.6T
Stock-based compensation	$1T

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	11.58
Book value per share	$118,403.60
Debt / EBITDA	0.37
Debt / equity	0.1
Debt / FCF	0.52
Goodwill	$1.7T
Interest coverage	369.14
Long-term assets	$21.3T
Long-term liabilities	$4.6T
Net cash (debt)	$17.3T
Net cash / market cap	8.51%
Net cash growth	11.07%
Net debt / EBITDA	-2.29
Net debt / equity	-0.58
Net debt / FCF	-3.07
Piotroski F-Score	5
Property, plant and equipment	$5.1T
Shareholders' equity	$30T
Tangible book value	$27.8T
Tangible book value per share	$109,627.38
Total assets	$40.6T
Total cash	$11.6T
Total debt	$2.9T
Total liabilities	$10.6T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.49
Current assets	$19.3T
Current liabilities	$6.1T
Current ratio	3.19
Inventory turnover	3.47
Net working capital	$1.1T
Quick ratio	2.54
Working capital	$12.7T
Working capital turnover	2,503.87

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.85%
Shareholder yield	0.85%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$4.94
1D price change	-5.03%
1M price change	0.18%
1M total return	0.18%
1W price change	4.98%
1W total return	4.98%
1Y price change	27.15%
1Y return CAGR	27.17%
1Y total return	27.15%
20-day SMA	$5.35
3M price change	12.3%
3M total return	12.3%
50-day SMA	$5.40
52-week high	$5.80
52-week high date	2026-09-08
52-week low	$4.20
52-week low date	2025-10-31
6M price change	22.32%
6M total return	22.32%
All-time high	$5.80
All-time high date	2026-09-08
All-time low	$3.63
All-time low date	2025-09-18
Average true range (ATR)	$0.16
Average volume	194.7
Change from 52-week high	-5.52%
Change from 52-week low	30.48%
Change from all-time high	-5.52%
Change from all-time low	50.96%
Change from open	0%
Day's gap	-5.03%
Dollar volume	$663
High price	$5.48
Low price	$5.48
Monthly RSI	74.87
Open price	$5.48
Previous close	$5.77
Price vs 150-day SMA	10.86%
Price vs 20-day SMA	2.49%
Price vs 50-day SMA	1.46%
Relative volume	0.62
RSI	53.41
Sharpe ratio	1.23
Sortino ratio	2.1
Volume	121
Weekly RSI	57
YTD price change	19.13%
YTD total return	19.13%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	252.7M
Shares change (QoQ)	-0.43%
Shares change (YoY)	-0.85%
Shares held by insiders	0.2%
Shares held by institutions	97.11%
Short ratio	3.6 days

Deeper analysis on BCBA/VRTXD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/VRTXD report

Is a complete BCBA/VRTXD research report available?

No complete published report is available for bcba/VRTXD (BCBA/VRTXD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/VRTXD (BCBA/VRTXD)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/VRTXD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/VRTXD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/VRTXD

Frequently asked questions